QUANTUM¿ MAVERICK¿
Report
- Report Number
- 2134265-2013-03479
- Event Type
- Malfunction
- Date Received
- May 15, 2013
- Date of Event
- March 6, 2013
- Report Date
- April 16, 2013
- Manufacturer
- BOSTON SCIENTIFIC - MAPLE GROVE
- Product Code
- LOX
- PMA / PMN Number
- P860019
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CN
- Reporter Occupation
- PHYSICIAN
Narratives
AGE AT TIME OF EVENT: 18 YEARS OR OLDER. (B)(4). DEVICE EVALUATED BY MANUFACTURER: RETURNED PRODUCT CONSISTED OF A QUANTUM MAVERICK BALLOON CATHETER WITH A STOPCOCK ATTACHED TO THE MANIFOLD. THE BALLOON WAS TIGHTLY FOLDED. THERE WAS A PINHOLE IN THE BALLOON WALL MATERIAL 6MM FROM THE PROXIMAL EDGE OF THE DISTAL MARKERBAND. THE BALLOON WALL MATERIAL HAD SCRATCHES. THE OUTER SHAFT WAS KINKED 1.75CM FROM THE DISTAL TIP. THE KINK AND SCRATCHES WERE ALIGNED WITH THE PINHOLE. INSPECTION OF THE DEVICE PRESENTED NO DAMAGE OR IRREGULARITIES. THE MANUFACTURING BATCH RECORD REVIEW CONFIRMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS OPERATIONAL CONTEXT AS DEVICE PERFORMANCE WAS LIMITED DUE TO ANATOMICAL PROCEDURAL FACTORS. (B)(4).
REPORTABLE BASED ON ANALYSIS COMPLETED ON (B)(4) 2013. IT WAS REPORTED THAT DURING A CORONARY STENTING TREATMENT PROCEDURE, DIFFICULTY CROSSING THE LESION OCCURRED. THE 80% RESTENOSED TARGET LESION WAS A DE NOVO LESION LOCATED IN THE MILDLY TORTUOUS LEFT ANTERIOR DESCENDING ARTERY. THE 15MM X 3.5MM QUANTUM MAVERICK BALLOON CATHETER COULD NOT CROSS THE LESION. THE PROCEDURE COMPLETED WITH ANOTHER OF THE SAME DEVICE. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT' STATUS WAS GOOD. HOWEVER, DEVICE ANALYSIS REVEALED A PINHOLE ON THE BALLOON WALL.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 215563 | QUANTUM¿ MAVERICK¿ | CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS | LOX | BOSTON SCIENTIFIC - MAPLE GROVE | H7493808015350 | 15329045 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 65 YR |